仁度生物: 2024年年度股东大会决议公告

Meeting Overview - The shareholders' meeting of Shanghai Rendu Biotechnology Co., Ltd. was held on May 22, 2025, at the company's conference room [1] - The meeting was attended by 29 ordinary shareholders, representing 24,640,020 voting rights, which accounts for 63.6552% of the total voting rights [1] Voting Results - All non-cumulative voting proposals were approved with significant majority support: - Proposal 1: 24,628,105 votes in favor (99.9516%), 11,915 votes against (0.0484%) [1] - Proposal 2: 24,627,022 votes in favor (99.9472%), 12,998 votes against (0.0528%) [2] - Proposal 3: 24,628,105 votes in favor (99.9516%), 11,915 votes against (0.0484%) [2] - Proposal 4: 21,783,210 votes in favor (99.9404%), 12,998 votes against (0.0596%) [2] - Proposal 5: 21,779,810 votes in favor (99.9248%), 12,998 votes against (0.0596%), and 3,400 abstentions (0.0156%) [2] Legal Compliance - The meeting's procedures, including the qualifications of attendees and voting processes, complied with the Company Law and the company's articles of association, as confirmed by the attending lawyers [3]